Phase 2 Trial to Test Exercise as Way to Improve Quality of Life in Recurring Ovarian Cancer

Phase 2 Trial to Test Exercise as Way to Improve Quality of Life in Recurring Ovarian Cancer
A new Phase 2 clinical trial in Australia will assess whether exercise can improve the quality of life and physical function of women with recurring ovarian cancer who are on chemotherapy. Researchers at Griffith University recently were awarded a AU$884,172 grant (about $581,000) from the Medical Research Future Fund for this project. They will collaborate with teams at University of Queensland, Queensland University of Technology, Mater Hospital Brisbane, Royal Brisbane and Women’s Hospital Foundation, and the Council of the Queensland Institute of Medical Research. Recurring ovarian cancer refers to ovarian cancer that comes back after an initial treatment. In general, "women with recurrent ovarian cancer report high treatment-related side effects and unmet supportive care needs," Sandi Hayes, the study's lead researcher and a professor at Menzies Health Institute Queensland, said in a press release. Current treatment of these patients is focused on maximizing duration and quality of life. According to Hayes, exercise therapy is recommended as part of the best-prac
Subscribe or to access all post and page content.